Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Sun Pharmaceutical Industries Limited Identifier:
First received: July 28, 2011
Last updated: September 30, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)